Ichnos Glenmark Innovation Shares Phase I Data on Novel Multiple Myeloma Therapy

In a breakthrough for cancer research, Ichnos Glenmark multiple myeloma therapy has shown promising results in its Phase I clinical trial. This innovative treatment offers new hope for patients battling…

Got news worth sharing?

Refpost Journal is your go-to platform to bring your story into the spotlight. Whether it's a groundbreaking announcement, a product launch, or a milestone achievement, we ensure your voice reaches the right audience.